Ecological Momentary Assessments of daily pain experiences in bothersome and high-impact chronic pain

This study utilized Ecological Momentary Assessments to reveal that while individuals with high-impact chronic pain experience significantly greater daily interference with activities compared to those with bothersome chronic pain, many other day-to-day pain experiences, including intensity, mood, and catastrophizing, remain surprisingly similar between the two groups.

The Gist

Imagine you are trying to understand two different types of travelers: The "Bothersome" Hiker and The "High-Impact" Hiker.

Both are walking the same difficult mountain trail (chronic pain). Both feel the same level of sharpness in their boots (pain intensity). But here is the twist: The "High-Impact" hiker is constantly stopping, sitting down, or turning back because the trail is blocking their path, while the "Bothersome" hiker keeps walking, even if they are grumbling a bit.

This study is like a team of researchers who decided to stop guessing what these hikers are thinking and started wearing a "smart camera" on their chests for a week. Instead of asking them at the end of the month, "How was your trip?" (which is easy to forget or exaggerate), the camera took a snapshot four times a day for seven days.

Here is what they found, translated into everyday language:

1. The Camera vs. The Memory Book

Usually, doctors ask patients to fill out a survey once a month: "On a scale of 1 to 10, how bad was your pain last month?"

• The Problem: Our brains are like bad librarians. We remember the worst moments (the "highlight reel" of pain) and forget the boring, okay moments. This is called recall bias.
• The Solution: This study used Ecological Momentary Assessment (EMA). Think of this as a "smart camera" that snaps a picture of your life every few hours. It asks, "What are you doing right now? How does it feel?" This gives a real-time, unedited video of life with pain, rather than a blurry memory.

2. The Two Groups: Same Pain, Different Lives

The researchers split the hikers into two groups based on how much the pain stopped them from living their lives:

• The "Bothersome" Group: They have pain often, but they can still do most things.
• The "High-Impact" Group: The pain is so disruptive it stops them from working, moving, or socializing regularly.

The Big Surprise:
When the researchers looked at the "pain intensity" (how sharp the pain felt), both groups felt the same amount of pain.

• Analogy: Imagine both hikers are carrying a 20-pound backpack. The weight is identical.
• The Difference: The "High-Impact" hiker has to stop every 10 minutes to rest, sit down, or lie in the grass because the backpack is blocking their path. The "Bothersome" hiker keeps walking, maybe slowing down a bit, but they don't stop.

3. What the "Smart Camera" Saw

The study looked at many details, like mood, sleep, and how people coped. Here are the key findings:

• Mood & Catastrophizing: You might think the "High-Impact" group would be much sadder or more panicked about their pain. Surprisingly, in their daily snapshots, their moods were about the same as the "Bothersome" group. They weren't necessarily more depressed in the moment; they were just more stopped by the pain.
• The "Stop" Signs (Interference): This was the biggest difference. The "High-Impact" group was constantly hitting "pause." They were more likely to:
  • Avoid moving or sitting still.
  • Lie down or go to bed.
  • Cancel plans with friends.
  • Struggle to focus on thoughts.
  • Analogy: It's like a computer with a virus. Both computers have the same processor speed (pain intensity), but the "High-Impact" computer keeps freezing and crashing, while the "Bothersome" one just runs a little slower.
• How They Coped: The "High-Impact" group tried harder to fix the problem. They used more "distraction" techniques, lay down more often, and tried mindfulness. They also described their pain with more intense words like "sharp," "deep," and "throbbing."
• The Overlap: Here is the most important part. Even though the "High-Impact" group stopped more often, there was a lot of overlap. Some people in the "Bothersome" group had days where they stopped just as much as the "High-Impact" group. It's not a black-and-white line; it's a gray area.

4. Why This Matters

Think of pain classification like sorting mail.

• Old Way: We sort mail by looking at the envelope (a single survey once a month). We might miss that the letter inside is urgent.
• New Way: This study suggests we should look at the contents of the letter every day.

The Takeaway:
The main thing that makes "High-Impact" pain different isn't that the pain hurts more; it's that the pain stops you from living more.

• If you have pain that feels the same as someone else's, but it forces you to cancel your plans, lie down, or stop working, you are in the "High-Impact" category.
• The study suggests that doctors shouldn't just ask, "How much does it hurt?" They should ask, "How often does it stop you from doing what you want to do?"

By using these "smart cameras" (daily check-ins), we can see the real story of pain: it's not just about the intensity of the signal, but how much that signal interrupts the movie of your life.

Technical Summary

1. Problem Statement

High-Impact Chronic Pain (HICP) is a significant public health challenge affecting approximately 8.5% of U.S. adults, characterized by persistent pain that substantially limits daily activities. While HICP is defined by activity limitations occurring "on most days or every day," current understanding relies heavily on retrospective self-reports. These retrospective methods are prone to recall bias, memory heuristics, and aggregation errors that obscure short-term fluctuations and the true nature of daily pain experiences.

There is a critical gap in knowledge regarding how HICP manifests in real-time, daily life compared to Bothersome Chronic Pain (BCP). Both groups experience frequent pain, but HICP is distinguished by higher interference with daily activities. Existing cross-sectional studies suggest differences in depression, anxiety, and catastrophizing, but it is unclear if these distinctions hold when assessed via high-resolution, momentary data in naturalistic settings.

2. Methodology

Study Design & Participants

• Data Source: Baseline data from an NIH-funded R61 project (R61NS118651) involving adults with chronic musculoskeletal pain (primarily low back pain).
• Sample: 107 participants were analyzed, classified using the Graded Chronic Pain Scale–Revised (GCPS-R):
  • HICP Group: $n = 66$ (Pain on most/every day with frequent activity limitation).
  • BCP Group: $n = 41$ (Pain on most/every day but less frequent activity limitation).
• Exclusion: Participants with inflammatory rheumatic diseases, non-musculoskeletal primary pain, or significant cognitive impairment were excluded.

Procedure: Ecological Momentary Assessment (EMA)

• Duration: 7 consecutive days.
• Frequency: 4 prompts per day (stratified random sampling across 4 time windows: 8–10 AM, 12–2 PM, 4–6 PM, 8–10 PM).
• Instrument: The comprehensive Ecological Momentary Assessment of pain (cEMAp).
  • Timeframe: 2-hour recall window (covering the period since the last prompt) combined with a momentary "right now" rating.
  • Domains Assessed: Pain intensity, interference, catastrophizing, behaviors, coping strategies, pain quality, pain locations, mood, and sleep.
  • Compliance: Overall compliance was 72%; the analytic sample required completion of at least 50% of prompts.

Statistical Analysis

• Continuous Variables: Aggregated at the person-level (averages across the week). Analyzed using ANCOVA controlling for age and sex.
• Categorical/Item-Level Variables: Analyzed using a two-stage approach:
  1. Composite Scores: Sum of endorsed items per prompt.
  2. Multivariate Analysis: MANCOVA (using Pillai's Trace for robustness) followed by ANCOVA with Benjamini–Hochberg FDR correction for individual items.
• Robustness Checks: Permutation-based sensitivity analyses (PERMANOVA and Freedman–Lane method) were conducted to address violations of homogeneity of covariance matrices.
• Distributional Analysis: Overlap indices (kernel density estimates) were calculated to quantify the similarity between group distributions (0 = no overlap, 1 = complete overlap).

3. Key Contributions

• First High-Resolution Comparison: This is the first study to utilize intensive EMA to compare the daily lives of individuals with HICP versus BCP, moving beyond retrospective aggregates.
• Disentangling Frequency vs. Intensity: The study successfully separates pain intensity from pain frequency in daily reporting, a distinction often lost in retrospective measures.
• Validation of GCPS-R in Daily Life: It provides empirical evidence for the "known-groups validity" of the GCPS-R classification by demonstrating that the primary differentiator (interference) holds true in real-time monitoring.
• Comprehensive Phenotyping: By utilizing cEMAp, the study captures a broader spectrum of pain experiences (e.g., specific coping strategies, pain qualities, and locations) than previous studies.

4. Key Results

Pain Intensity

• Momentary Intensity: No significant difference between HICP and BCP groups ($p = .13$).
• Conditional Intensity (when pain is present): No significant difference ($p = .19$).
• Non-Conditional Intensity (incorporating frequency): The HICP group reported significantly higher weekly average pain intensity ($M=3.98$ vs. $3.35$, $p=.026$).
  • Interpretation: The difference in HICP is driven by more frequent pain episodes, not higher intensity when pain occurs.

Pain Interference (Primary Differentiator)

• Significant Group Differences: HICP participants reported significantly higher interference across physical, mental, and social domains.
• Specific Behaviors: HICP group more frequently reported:
  • Avoiding movement/sedentary behavior ($\eta^2_p = .17$, large effect).
  • Doing less than wanted ($\eta^2_p = .09$).
  • Impaired thinking/concentration.
  • Isolating/cancelling plans.
• Overlap: Despite mean differences, the distributional overlap for interference was moderate (.43), indicating significant heterogeneity within groups.

Other Domains

• Mood & Catastrophizing: Contrary to retrospective literature, no significant differences were found between groups in daily mood or pain catastrophizing.
• Pain Quality: HICP group more frequently described pain as sharp, deep, and throbbing.
• Coping Strategies: HICP group more frequently used distraction, lying down/resting, and mindfulness/meditation.
• Pain Locations: HICP group reported pain in legs/thighs/glutes and hands/wrists/fingers more frequently.
• Pain Behaviors: While composite scores differed, individual behavior items (limping, bracing) did not remain significant after FDR correction, though unadjusted trends favored HICP.

Distributional Overlap

• High overlap was observed for pain intensity (.72–.86) and sleep quality (.83).
• Lower overlap (indicating better separation) was found for pain interference (.43) and pain quality (.46).
• Conclusion: While group means differ, there is substantial individual-level overlap; some BCP individuals experience HICP-like burdens.

5. Significance and Implications

Clinical Implications

• Refining Diagnosis: The findings suggest that functional interference is the most robust daily differentiator between HICP and BCP, rather than pain intensity or affective state.
• Monitoring: Brief, real-world sampling of functional impact could complement retrospective screening to identify patients whose daily impairment is under-recognized by categorical tools.
• Treatment: Interventions for HICP may need to focus more heavily on activity pacing, movement avoidance, and cognitive interference rather than solely on pain intensity reduction or emotional regulation.

Research Implications

• Methodological Shift: Relying solely on single-timepoint retrospective assessments may obscure critical nuances. Future classifications of chronic pain subgroups should consider integrating intensive daily sampling (EMA) to capture phenotypic heterogeneity.
• Biomarker Integration: Combining EMA-derived functional phenotypes with longitudinal outcomes and biomarker data could improve the prediction of prognosis and treatment response.

Limitations

• The sample was modest ($N=107$) and predominantly had chronic low back pain, limiting generalizability to other pain conditions.
• Data covered only a single week, which may not capture long-term stability.
• Affect was measured via a single item, potentially lacking nuance.

In summary, the study demonstrates that while HICP and BCP groups share similar pain intensities and emotional states in daily life, they are distinctly separated by the frequency and severity of functional interference, highlighting the need for dynamic, real-world assessment tools in pain research and clinical practice.